Quell QE-STX
Quell QE-STX is a medical device (FDA Class II; FDA product code QSQ, Transcutaneous Electrical Nerve Stimulator To Treat Fibromyalgia Symptoms) made by Neurometrix, Inc., granted FDA De Novo DEN210046 on 18 May 2022 and listed in FDA GUDID since 1 Aug 2025 (UDI-DI 00851221006704), active as of 22 Oct 2026.
Active
De Novo
Valid until
No expiry
FDA recalls
None found
Documents
Trust
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| United States | GUDID listing | Number00851221006704 | Date1 Aug 2025 | StatusListed |
| United States | FDA De NovoDENG | NumberDEN210046 | Date18 May 2022 | StatusActive |
Official records
- AccessGUDID record 00851221006704
- FDA De Novo database DEN210046
From the FDA record
- Device description
- Extension Band
- MRI safety
- Labeling does not contain MRI Safety Information
- Natural rubber latex
- Labelled as not made with natural rubber latex
- Sterility
- Supplied non-sterile
Across registries
- FDA De Novo DEN210046 decided 18 May 2022 Active
- FDA GUDID UDI-DI 00851221006704 listed 1 Aug 2025 Listed
Timeline
- Granted FDA De Novo DEN210046
- Listed FDA GUDID 00851221006704
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not covered
United States — FDA De Novo Active
Specification
- Trade name
- Quell
- Generic name
- Analgesic transcutaneous electrical nerve stimulation system
- Model / reference
- QE-STX
- Primary DI / UDI-DI
- 00851221006704
- De Novo Number
- FDA product code
- QSQ
- GMDN term
- Analgesic transcutaneous electrical nerve stimulation system
- Device class
- Class II
- Regulation number
- 882.5888
- GUDID distribution status
- In Commercial Distribution
Similar devices in this category
Other devices filed under Analgesic transcutaneous electrical nerve stimulation system.